IMPRINTS.CETSA and IMPRINTS.CETSA.app: an R package and a Shiny application for the analysis and interpretation of IMPRINTS-CETSA data.

Live

The Marseille Cancer Research Center celebrates its 50th anniversary ! -

Photo de profil par défault
Mar 2024 Briefings in bioinformatics

IMPRINTS.CETSA and IMPRINTS.CETSA.app: an R package and a Shiny application for the analysis and interpretation of IMPRINTS-CETSA data.

Gerault MA, Granjeaud S, Camoin L, Nordlund P, Dai L

Photo de profil par défault
Feb 2024 EMBO reports

mTert induction in p21-positive cells counteracts capillary rarefaction and pulmonary emphysema.

Lipskaia L, Breau M, Cayrou C, Churikov D, Braud L, Jacquet J, Born E, Fouillade C, Curras-Alonso S, Bauwens S, Jourquin F, Fiore F, Castellano R, Josselin E, Sánchez-Ferrer C, Giovinazzo G, Lachaud C, Gilson E, Flores I, Londono-Vallejo A, Adnot S, Géli V

Photo de profil par défault
Feb 2024 EMBO molecular medicine

Targeting NUPR1-dependent stress granules formation to induce synthetic lethality in Kras-driven tumors.

Santofimia-Castaño P, Fraunhoffer N, Liu X, Bessone IF, di Magliano MP, Audebert S, Camoin L, Estaras M, Brenière M, Modesti M, Lomberk G, Urrutia R, Soubeyran P, Neira JL, Iovanna J

Photo de profil par défault
Feb 2024 The Journal of biological chemistry

A vertebrate Vangl2 translational variant required for planar cell polarity.

Walton A, Thomé V, Revinski D, Marchetto S, Puvirajesinghe TM, Audebert S, Camoin L, Bailly E, Kodjabachian L, Borg JP

Photo de profil par défault
Jan 2024 Bioinformatics advances

DIAgui: a Shiny application to process the output from DIA-NN.

Gerault MA, Camoin L, Granjeaud S

Photo de profil par défault
Dec 2023 Biochimica et biophysica acta. Proteins and proteomics

PDZome-wide and structural characterization of the PDZ-binding motif of VANGL2.

Montserrat-Gomez M, Gogl G, Carrasco K, Betzi S, Durbesson F, Cousido-Siah A, Kostmann C, Essig DJ, Strømgaard K, Østergaard S, Morelli X, Trave G, Vincentelli R, Bailly E, Borg JP

Photo de profil par défault
Dec 2023 Molecular cancer therapeutics

4′-Ethynyl-2′-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress.

Calbert ML, Chandramouly G, Adams CM, Saez-Ayala M, Kent T, Tyagi M, Ayyadevara VSSA, Wang Y, Krais JJ, Gordon J, Atkins J, Toma MM, Betzi S, Boghossian AS, Rees MG, Ronan MM, Roth JA, Goldman AR, Gorman N, Mitra R, Childers WE, Graña X, Skorski T, Johnson N, Hurtz C, Morelli X, Eischen CM, Pomerantz RT

Photo de profil par défault
Oct 2023 EMBO molecular medicine

Downregulation of stromal syntenin sustains AML development.

Leblanc R, Ghossoub R, Goubard A, Castellano R, Fares J, Camoin L, Audebert S, Balzano M, Bou-Tayeh B, Fauriat C, Vey N, Garciaz S, Borg JP, Collette Y, Aurrand-Lions M, David G, Zimmermann P

Photo de profil par défault
Sep 2023 Proceedings of the National Academy of Sciences of the United States of America

PDZ scaffolds regulate extracellular vesicle production, composition, and uptake.

Castro-Cruz M, Hyka L, Daaboul G, Leblanc R, Meeussen S, Lembo F, Oris A, Van Herck L, Granjeaud S, David G, Zimmermann P

Jul 2023 BMC biology

Population transcriptogenomics highlights impaired metabolism and small population sizes in tree frogs living in the Chernobyl Exclusion Zone.

Car C, Gilles A, Goujon E, Muller MD, Camoin L, Frelon S, Burraco P, Granjeaud S, Baudelet E, Audebert S, Orizaola G, Armengaud J, Tenenhaus A, Garali I, Bonzom JM, Armant O